Article info
PDFPostScript
Letter
Mepolizumab in refractory eosinophilic asthma
- Correspondence to Professor I D Pavord, Institute for Lung Health, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester LE3 9QP, UK; ian.pavord{at}uhl-tr.nhs.uk
Citation
Mepolizumab in refractory eosinophilic asthma
Publication history
- Accepted July 9, 2009
- First published April 13, 2010.
Online issue publication
September 01, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.